Observational Study Comparing Home to Office Spirometry
NCT ID: NCT05285410
Last Updated: 2024-01-11
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
116 participants
OBSERVATIONAL
2022-11-30
2023-12-19
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Pilot Observational Study to Determine Feasibility of a Standardized Treatment of Pulmonary Exacerb. in Patients With CF
NCT02109822
Strength and Muscle Related Outcomes for Nutrition and Lung Function in CF
NCT05639556
Reproducibility of Virtual Exercise Assessments Versus Face-to-face Exercise Testing in Adults With Cystic Fibrosis
NCT06565832
Early Intervention in Pulmonary Exacerbation in Cystic Fibrosis
NCT00850551
Tele-Coaching Intervention to Improve Treatment Adherence in Cystic Fibrosis
NCT03921229
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Clinically stable
* ≥6 years of age at Screening Visit
* During the run-in period, performed acceptable home spirometry at least twice without virtually coaching and once with virtually coaching
Exclusion Criteria
* Initiation of a highly effective modulator therapy within 2 months before Screening Visit
6 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Washington
OTHER
University of Arkansas
OTHER
Harvard University
OTHER
Cystic Fibrosis Foundation
OTHER
Chris Goss
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Chris Goss
Professor of Medicine and Pediatrics, University of Washington
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Margaret Rosenfeld, MD, MPH
Role: PRINCIPAL_INVESTIGATOR
University of Washington, Seattle Children's Research Institute
Ariel Berlinski, MD
Role: PRINCIPAL_INVESTIGATOR
University of Arkansas for Med. Sciences, Arkansas Children's Hospital
Andrea Hartzler, PhD
Role: PRINCIPAL_INVESTIGATOR
University of Washington
Greg Sawicki, MD, MPH
Role: PRINCIPAL_INVESTIGATOR
Harvard University and Boston Children's Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Providence Alaska Medical Center
Anchorage, Alaska, United States
Arkansas Children's Hospital
Little Rock, Arkansas, United States
OSF Saint Francis Medical Center
Peoria, Illinois, United States
Boston Children's Hospital
Boston, Massachusetts, United States
Wayne State University Harper University Hospital
Detroit, Michigan, United States
Helen DeVos Children's Hospital
Grand Rapids, Michigan, United States
St. Louis Children's Hospital
St Louis, Missouri, United States
Lenox Hill Hospital Cystic Fibrosis Center
New York, New York, United States
Wake Forest University Baptist Medical Center
Winston-Salem, North Carolina, United States
Children's Hospital Medical Center of Akron
Akron, Ohio, United States
Toledo Children's Hospital
Toledo, Ohio, United States
Oregon Health Sciences University
Portland, Oregon, United States
Jefferson University Hospital
Philadelphia, Pennsylvania, United States
University of South Carolina School of Medicine
Columbia, South Carolina, United States
Sanford USD Medical Center
Sioux Falls, South Dakota, United States
The Adult Cystic Fibrosis Center of Central Texas
Austin, Texas, United States
Seattle Children's Hospital
Seattle, Washington, United States
Providence Medical Group, Cystic Fibrosis Clinic - Pediatrics
Spokane, Washington, United States
Froedtert & Medical College of Wisconsin
Milwaukee, Wisconsin, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
OUTREACH-OB-22
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.